Patients initiating GLP-1 RA treatment (semaglutide, liraglutide, tirzepatide) were propensity scorematched (1:1) with RA controls not receiving GLP-1 RA therapy, balancing demographics, BMI categories, cardiovascular comorbidities, immunosuppressive therapies, and cardiometabolic medications
Same doctor, every visit
Some patients prefer morning administration to align with their daily routine, whilst others find evening dosing more convenient
Steps and methods of pharmaceutical health technology assessment
Always clean the injection site with an alcohol swab and let it air dry before injecting
Analyze Your Past Weight Loss Efforts Begin preparing for your appointment by making a note of your prior weight loss attempts, how long you tried them for, and why they did or did not work